Centre for Infectious Diseases, Queen Astrid Military Hospital, Brussels, Belgium.
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Acta Clin Belg. 2021 Apr;76(2):91-97. doi: 10.1080/17843286.2019.1662993. Epub 2019 Sep 4.
: Data on rabies post-exposure prophylaxis (PEP) and the use of human rabies immunoglobulins (HRIG) in Belgium are scarce. The main objective of this study was to evaluate the timely administration of HRIG after rabies exposure. The secondary objective was to evaluate the adequate antibody response following PEP.: We reviewed all medical records from July 2017 to June 2018 of patients seeking care at, or referred to, the Institute of Tropical Medicine and the University Hospital, Antwerp for the administration of human rabies immunoglobulins following potential rabies exposure abroad or in Belgium.A timely response was defined as starting HRIG with a delay of ≤48 h and rabies vaccination in the first 7 days after exposure.Adequate antibody response was defined as a titer of >5.0 IU/mL in case of bat-related exposure and >3.0 IU/mL in case of exposure to other animals. Titers were measured 10 days after the last PEP vaccine dose, using the rapid fluorescent focus inhibition test (RFFIT).: Of the 92 cases treated with HRIG, 75 were evaluated.The majority of injuries were acquired in Asia (n = 26,34%) and in Western Europe (n = 18, 24%), of which 17 in Belgium. The five most frequently recorded countries overseas were Indonesia (n = 13), Thailand (n = 7), Morocco (n = 4), Peru (n = 3) and Costa Rica (n = 3). Administration of immunoglobulins was related to injuries by dogs (36%), monkeys (25%) or bats (22%).A timely response was observed in 16 (21,33%) and in 55 (73,33%) of subjects receiving HRIG (≤48 h) or rabies vaccine (<7days) respectively. The mean time between exposure and the first administered dose of rabies vaccine and HRIG was 7.7 and 8.7 days, respectively. The mean delay for HRIG administration was 9.6 days and 6 days for abroad and inland risks, respectively.In 15 of 16 (94%) bat-related cases the antibody titer after full PEP was >5.0 IU/ml. In 38 of 47 (81%) cases related to other animals the RFFIT titer was >3.0 IU/ml. All low-responders received additional rabies injections.: This study showed a substantial time delay between the animal-related risk and the administration of HRIG, in particular when the injury occurred abroad. More targeted communication about the risks of rabies and preventable measures may reduce this delay.Furthermore, the antibody response was inadequate in some cases following full PEP administration according to the Belgian recommendation.
: 比利时有关狂犬病暴露后预防 (PEP) 和人用狂犬病免疫球蛋白 (HRIG) 使用的数据很少。本研究的主要目的是评估 HRIG 在狂犬病暴露后的及时给药。次要目的是评估 PEP 后适当的抗体反应。: 我们回顾了 2017 年 7 月至 2018 年 6 月期间,在安特卫普热带医学研究所和大学医院寻求治疗或转诊的所有患者的医疗记录,这些患者在国外或比利时因潜在的狂犬病暴露而接受 HRIG 治疗。及时反应定义为 HRIG 在暴露后 48 小时内开始给药,狂犬病疫苗在暴露后 7 天内接种。适当的抗体反应定义为在蝙蝠相关暴露的情况下抗体滴度>5.0 IU/mL,在其他动物相关暴露的情况下抗体滴度>3.0 IU/mL。在最后一次 PEP 疫苗接种后 10 天,使用快速荧光灶抑制试验 (RFFIT) 测量滴度。: 在接受 HRIG 治疗的 92 例病例中,有 75 例进行了评估。大多数损伤发生在亚洲 (n = 26,34%) 和西欧 (n = 18,24%),其中 17 例在比利时。海外记录最多的五个国家分别是印度尼西亚 (n = 13)、泰国 (n = 7)、摩洛哥 (n = 4)、秘鲁 (n = 3) 和哥斯达黎加 (n = 3)。免疫球蛋白的使用与狗 (36%)、猴子 (25%)或蝙蝠 (22%) 引起的损伤有关。在接受 HRIG (≤48 小时) 或狂犬病疫苗 (<7 天) 的 16 名受试者中,分别观察到 16 名 (21.33%) 和 55 名 (73.33%) 的及时反应。暴露后和第一次接种狂犬病疫苗和 HRIG 的平均时间分别为 7.7 和 8.7 天。HRIG 给药的平均延迟时间分别为国外风险 9.6 天和国内风险 6 天。在 15 例 (94%) 与蝙蝠相关的病例中,完整 PEP 后的抗体滴度>5.0 IU/ml。在 47 例与其他动物相关的病例中,38 例 (81%) 的 RFFIT 滴度>3.0 IU/ml。所有低反应者都接受了额外的狂犬病注射。: 这项研究表明,在动物相关风险和 HRIG 给药之间存在大量的时间延迟,尤其是当损伤发生在国外时。关于狂犬病风险和可预防措施的更有针对性的沟通可能会减少这种延迟。此外,根据比利时的建议,在接受完整 PEP 治疗后,某些情况下抗体反应不足。